These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11853939)

  • 21. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
    Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs.
    Nagahara N; Tavelin S; Artursson P
    J Pharm Sci; 2004 Dec; 93(12):2972-84. PubMed ID: 15459946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transport properties of ionic drugs in the ammonio methacrylate copolymer membranes.
    Sun YM; Hsu SC; Lai JY
    Pharm Res; 2001 Mar; 18(3):304-10. PubMed ID: 11442269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.
    Ochalek M; Podhaisky H; Ruettinger HH; Wohlrab J; Neubert RH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):360-6. PubMed ID: 22750439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations.
    Sugawara M; Kadomura S; He X; Takekuma Y; Kohri N; Miyazaki K
    Eur J Pharm Sci; 2005 Sep; 26(1):1-8. PubMed ID: 15961297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion study.
    Ng SF; Rouse JJ; Sanderson FD; Eccleston GM
    Arch Pharm Res; 2012 Mar; 35(4):579-93. PubMed ID: 22553050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)].
    Fürst W; Neubert R; Reppel L
    Pharmazie; 1980 Feb; 35(2):106-9. PubMed ID: 7384178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing.
    Másson M; Loftsson T; Másson G; Stefánsson E
    J Control Release; 1999 May; 59(1):107-18. PubMed ID: 10210727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
    Fang JY; Hung CF; Chi CH; Chen CC
    Int J Pharm; 2009 Oct; 380(1-2):33-9. PubMed ID: 19563870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH- and sugar-sensitive layer-by-layer films and microcapsules for drug delivery.
    Sato K; Yoshida K; Takahashi S; Anzai J
    Adv Drug Deliv Rev; 2011 Aug; 63(9):809-21. PubMed ID: 21510988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecule delivery across a perforated artificial membrane by thermoreversible hydrogel poloxamer 407.
    Santimetaneedol A; Wang Z; Arteaga DN; Aksit A; Prevoteau C; Yu M; Chiang H; Fafalis D; Lalwani AK; Kysar JW
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110300. PubMed ID: 31326623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vehicle-dependent in situ modification of membrane-controlled drug release.
    Imanidis G; Helbing-Strausak S; Imboden R; Leuenberger H
    J Control Release; 1998 Jan; 51(1):23-34. PubMed ID: 9685901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permeability through DOPC/dodecane membranes: measurement and LFER modelling.
    Huque FT; Box K; Platts JA; Comer J
    Eur J Pharm Sci; 2004 Nov; 23(3):223-32. PubMed ID: 15489123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive drug permeation through membranes and cellular distribution.
    Scott DO; Ghosh A; Di L; Maurer TS
    Pharmacol Res; 2017 Mar; 117():94-102. PubMed ID: 27890815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of the hydrogen ion concentration on membrane transport of dissociated drugs from saturated solutions].
    Lippold BH; Lichey JF
    Pharmazie; 1986 Oct; 41(10):717-9. PubMed ID: 3823115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport of drugs across porous ion exchange membranes.
    Akerman S; Viinikka P; Svarfvar B; Järvinen K; Kontturi K; Näsman J; Urtti A; Paronen P
    J Control Release; 1998 Jan; 50(1-3):153-66. PubMed ID: 9685882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A flow diffusion chamber for research on cells in culture].
    Akamov VS; Lavrovskaia VP; Grobova ME; Lezhnev EI
    Tsitologiia; 1990; 32(4):399-404. PubMed ID: 2238113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug permeability profiling using cell-free permeation tools: Overview and applications.
    Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.